Do analysts prefer PHG or MDLN?

Medline has a consensus target price of $50.54, suggesting a potential upside of 24.88%. Given Medline's stronger consensus rating and higher probable upside, analysts plainly believe Medline is more favorable than Koninklijke Philips. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Koninklijke Philips 1 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.80 Medline 1 Sell rating(s) 5 Hold rating(s) 22 Buy rating(s) 1 Strong Buy rating(s) 2.79

Does the media favor PHG or MDLN?

In the previous week, Koninklijke Philips had 5 more articles in the media than Medline. MarketBeat recorded 14 mentions for Koninklijke Philips and 9 mentions for Medline. Medline's average media sentiment score of 0.86 beat Koninklijke Philips' score of 0.56 indicating that Medline is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Koninklijke Philips 6 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive Medline 5 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend PHG or GEHC?

GE HealthCare Technologies has a consensus price target of $77.73, suggesting a potential upside of 11.47%. Given GE HealthCare Technologies' stronger consensus rating and higher possible upside, analysts clearly believe GE HealthCare Technologies is more favorable than Koninklijke Philips. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Koninklijke Philips 1 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.80 GE HealthCare Technologies 1 Sell rating(s) 10 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.43

Does the media favor PHG or GEHC?

In the previous week, GE HealthCare Technologies had 45 more articles in the media than Koninklijke Philips. MarketBeat recorded 59 mentions for GE HealthCare Technologies and 14 mentions for Koninklijke Philips. GE HealthCare Technologies' average media sentiment score of 0.88 beat Koninklijke Philips' score of 0.56 indicating that GE HealthCare Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Koninklijke Philips 6 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive GE HealthCare Technologies 29 Very Positive mention(s) 6 Positive mention(s) 19 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend ZBH or PHG?

Zimmer Biomet presently has a consensus target price of $102.00, indicating a potential upside of 5.24%. Given Zimmer Biomet's stronger consensus rating and higher possible upside, equities research analysts clearly believe Zimmer Biomet is more favorable than Koninklijke Philips. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zimmer Biomet 4 Sell rating(s) 12 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.24 Koninklijke Philips 1 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.80

Does the media refer more to ZBH or PHG?

In the previous week, Zimmer Biomet had 3 more articles in the media than Koninklijke Philips. MarketBeat recorded 17 mentions for Zimmer Biomet and 14 mentions for Koninklijke Philips. Zimmer Biomet's average media sentiment score of 0.90 beat Koninklijke Philips' score of 0.56 indicating that Zimmer Biomet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zimmer Biomet 9 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Koninklijke Philips 6 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive

Do analysts recommend SOLV or PHG?

Solventum presently has a consensus price target of $86.00, suggesting a potential downside of 2.22%. Given Solventum's stronger consensus rating and higher probable upside, analysts plainly believe Solventum is more favorable than Koninklijke Philips. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Solventum 1 Sell rating(s) 5 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.46 Koninklijke Philips 1 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.80

Does the media favor SOLV or PHG?

In the previous week, Koninklijke Philips had 3 more articles in the media than Solventum. MarketBeat recorded 14 mentions for Koninklijke Philips and 11 mentions for Solventum. Solventum's average media sentiment score of 0.87 beat Koninklijke Philips' score of 0.56 indicating that Solventum is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Solventum 5 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Koninklijke Philips 6 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive

Do analysts prefer SNN or PHG?

Smith & Nephew SNATS presently has a consensus target price of $30.93, indicating a potential downside of 4.05%. Given Smith & Nephew SNATS's stronger consensus rating and higher probable upside, equities analysts plainly believe Smith & Nephew SNATS is more favorable than Koninklijke Philips. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Smith & Nephew SNATS 0 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.17 Koninklijke Philips 1 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.80

Which has better valuation & earnings, SNN or PHG?

Koninklijke Philips has higher revenue and earnings than Smith & Nephew SNATS. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Smith & Nephew SNATS $6.16B 2.21 $625M N/A N/A Koninklijke Philips $20.17B 1.28 $1.01B $1.36 19.28

Does the media refer more to SNN or PHG?

In the previous week, Koninklijke Philips had 9 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 14 mentions for Koninklijke Philips and 5 mentions for Smith & Nephew SNATS. Koninklijke Philips' average media sentiment score of 0.56 beat Smith & Nephew SNATS's score of 0.54 indicating that Koninklijke Philips is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Smith & Nephew SNATS 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Koninklijke Philips 6 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive

Koninklijke Philips (PHG) Competitors

$26.22 -0.09 (-0.32%)

Closing price 08/3/2026 03:59 PM Eastern

Extended Trading

$26.22 +0.01 (+0.04%)

As of 08/3/2026 07:34 PM Eastern

Compare

PHG vs. MDLN, GEHC, ZBH, SOLV, and SNN

Should you buy Koninklijke Philips stock or one of its competitors? MarketBeat compares Koninklijke Philips with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Koninklijke Philips include Medline (MDLN), GE HealthCare Technologies (GEHC), Zimmer Biomet (ZBH), Solventum (SOLV), and Smith & Nephew SNATS (SNN).

How does Koninklijke Philips compare to Medline?

Koninklijke Philips (NYSE:PHG) and Medline (NASDAQ:MDLN) are both large-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, media sentiment, earnings, risk, valuation and dividends.

In the previous week, Koninklijke Philips had 5 more articles in the media than Medline. MarketBeat recorded 14 mentions for Koninklijke Philips and 9 mentions for Medline. Medline's average media sentiment score of 0.86 beat Koninklijke Philips' score of 0.56 indicating that Medline is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Koninklijke Philips	6 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive
Medline	5 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Koninklijke Philips has a net margin of 6.30% compared to Medline's net margin of 0.00%. Koninklijke Philips' return on equity of 14.38% beat Medline's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Koninklijke Philips	6.30%	14.38%	5.96%
Medline	N/A	N/A	N/A

Medline has a consensus target price of $50.54, suggesting a potential upside of 24.88%. Given Medline's stronger consensus rating and higher probable upside, analysts plainly believe Medline is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Koninklijke Philips	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80
Medline	1 Sell rating(s)	5 Hold rating(s)	22 Buy rating(s)	1 Strong Buy rating(s)	2.79

Medline has higher revenue and earnings than Koninklijke Philips. Koninklijke Philips is trading at a lower price-to-earnings ratio than Medline, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Koninklijke Philips	$20.17B	1.28	$1.01B	$1.36	19.28
Medline	$28.43B	1.87	$1.16B	$0.32	126.47

13.7% of Koninklijke Philips shares are held by institutional investors. 0.8% of Medline shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Medline beats Koninklijke Philips on 10 of the 16 factors compared between the two stocks.

How does Koninklijke Philips compare to GE HealthCare Technologies?

Koninklijke Philips (NYSE:PHG) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, dividends, profitability, earnings, valuation and media sentiment.

In the previous week, GE HealthCare Technologies had 45 more articles in the media than Koninklijke Philips. MarketBeat recorded 59 mentions for GE HealthCare Technologies and 14 mentions for Koninklijke Philips. GE HealthCare Technologies' average media sentiment score of 0.88 beat Koninklijke Philips' score of 0.56 indicating that GE HealthCare Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Koninklijke Philips	6 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive
GE HealthCare Technologies	29 Very Positive mention(s)	6 Positive mention(s)	19 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

13.7% of Koninklijke Philips shares are owned by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are owned by institutional investors. 0.4% of GE HealthCare Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

GE HealthCare Technologies has a net margin of 9.33% compared to Koninklijke Philips' net margin of 6.30%. GE HealthCare Technologies' return on equity of 20.12% beat Koninklijke Philips' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Koninklijke Philips	6.30%	14.38%	5.96%
GE HealthCare Technologies	9.33%	20.12%	5.74%

Koninklijke Philips has a beta of 0.76, suggesting that its stock price is 24% less volatile than the broader market. Comparatively, GE HealthCare Technologies has a beta of 0.72, suggesting that its stock price is 28% less volatile than the broader market.

Koninklijke Philips pays an annual dividend of $0.84 per share and has a dividend yield of 3.2%. GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Koninklijke Philips pays out 61.8% of its earnings in the form of a dividend. GE HealthCare Technologies pays out 3.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. GE HealthCare Technologies has increased its dividend for 1 consecutive years.

GE HealthCare Technologies has higher revenue and earnings than Koninklijke Philips. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Koninklijke Philips, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Koninklijke Philips	$20.17B	1.28	$1.01B	$1.36	19.28
GE HealthCare Technologies	$21.27B	1.48	$2.08B	$4.36	15.99

GE HealthCare Technologies has a consensus price target of $77.73, suggesting a potential upside of 11.47%. Given GE HealthCare Technologies' stronger consensus rating and higher possible upside, analysts clearly believe GE HealthCare Technologies is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Koninklijke Philips	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80
GE HealthCare Technologies	1 Sell rating(s)	10 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.43

Summary

GE HealthCare Technologies beats Koninklijke Philips on 15 of the 19 factors compared between the two stocks.

How does Koninklijke Philips compare to Zimmer Biomet?

Zimmer Biomet (NYSE:ZBH) and Koninklijke Philips (NYSE:PHG) are both large-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk.

Zimmer Biomet has a net margin of 9.05% compared to Koninklijke Philips' net margin of 6.30%. Koninklijke Philips' return on equity of 14.38% beat Zimmer Biomet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zimmer Biomet	9.05%	13.24%	7.28%
Koninklijke Philips	6.30%	14.38%	5.96%

Koninklijke Philips has higher revenue and earnings than Zimmer Biomet. Koninklijke Philips is trading at a lower price-to-earnings ratio than Zimmer Biomet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zimmer Biomet	$8.23B	2.28	$705.20M	$3.85	25.17
Koninklijke Philips	$20.17B	1.28	$1.01B	$1.36	19.28

88.9% of Zimmer Biomet shares are owned by institutional investors. Comparatively, 13.7% of Koninklijke Philips shares are owned by institutional investors. 1.3% of Zimmer Biomet shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Zimmer Biomet presently has a consensus target price of $102.00, indicating a potential upside of 5.24%. Given Zimmer Biomet's stronger consensus rating and higher possible upside, equities research analysts clearly believe Zimmer Biomet is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zimmer Biomet	4 Sell rating(s)	12 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.24
Koninklijke Philips	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80

Zimmer Biomet pays an annual dividend of $0.96 per share and has a dividend yield of 1.0%. Koninklijke Philips pays an annual dividend of $0.84 per share and has a dividend yield of 3.2%. Zimmer Biomet pays out 24.9% of its earnings in the form of a dividend. Koninklijke Philips pays out 61.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Zimmer Biomet has a beta of 0.45, suggesting that its share price is 55% less volatile than the broader market. Comparatively, Koninklijke Philips has a beta of 0.76, suggesting that its share price is 24% less volatile than the broader market.

In the previous week, Zimmer Biomet had 3 more articles in the media than Koninklijke Philips. MarketBeat recorded 17 mentions for Zimmer Biomet and 14 mentions for Koninklijke Philips. Zimmer Biomet's average media sentiment score of 0.90 beat Koninklijke Philips' score of 0.56 indicating that Zimmer Biomet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zimmer Biomet	9 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Koninklijke Philips	6 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive

Summary

Zimmer Biomet beats Koninklijke Philips on 14 of the 19 factors compared between the two stocks.

How does Koninklijke Philips compare to Solventum?

Solventum (NYSE:SOLV) and Koninklijke Philips (NYSE:PHG) are both large-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, risk, dividends, valuation, media sentiment and earnings.

In the previous week, Koninklijke Philips had 3 more articles in the media than Solventum. MarketBeat recorded 14 mentions for Koninklijke Philips and 11 mentions for Solventum. Solventum's average media sentiment score of 0.87 beat Koninklijke Philips' score of 0.56 indicating that Solventum is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Solventum	5 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Koninklijke Philips	6 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive

Solventum has a beta of 0.6, meaning that its share price is 40% less volatile than the broader market. Comparatively, Koninklijke Philips has a beta of 0.76, meaning that its share price is 24% less volatile than the broader market.

13.7% of Koninklijke Philips shares are held by institutional investors. 0.2% of Solventum shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Solventum presently has a consensus price target of $86.00, suggesting a potential downside of 2.22%. Given Solventum's stronger consensus rating and higher probable upside, analysts plainly believe Solventum is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solventum	1 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.46
Koninklijke Philips	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80

Solventum has higher earnings, but lower revenue than Koninklijke Philips. Solventum is trading at a lower price-to-earnings ratio than Koninklijke Philips, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Solventum	$8.33B	1.83	$1.56B	$8.16	10.78
Koninklijke Philips	$20.17B	1.28	$1.01B	$1.36	19.28

Solventum has a net margin of 17.33% compared to Koninklijke Philips' net margin of 6.30%. Solventum's return on equity of 23.51% beat Koninklijke Philips' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Solventum	17.33%	23.51%	7.63%
Koninklijke Philips	6.30%	14.38%	5.96%

Summary

Solventum beats Koninklijke Philips on 11 of the 16 factors compared between the two stocks.

How does Koninklijke Philips compare to Smith & Nephew SNATS?

Smith & Nephew SNATS (NYSE:SNN) and Koninklijke Philips (NYSE:PHG) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, valuation, analyst recommendations, risk, institutional ownership, profitability and earnings.

Koninklijke Philips has a net margin of 6.30% compared to Smith & Nephew SNATS's net margin of 0.00%. Koninklijke Philips' return on equity of 14.38% beat Smith & Nephew SNATS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Smith & Nephew SNATS	N/A	N/A	N/A
Koninklijke Philips	6.30%	14.38%	5.96%

Smith & Nephew SNATS has a beta of 0.55, meaning that its stock price is 45% less volatile than the broader market. Comparatively, Koninklijke Philips has a beta of 0.76, meaning that its stock price is 24% less volatile than the broader market.

Smith & Nephew SNATS pays an annual dividend of $0.93 per share and has a dividend yield of 2.9%. Koninklijke Philips pays an annual dividend of $0.84 per share and has a dividend yield of 3.2%. Koninklijke Philips pays out 61.8% of its earnings in the form of a dividend.

25.6% of Smith & Nephew SNATS shares are held by institutional investors. Comparatively, 13.7% of Koninklijke Philips shares are held by institutional investors. 1.0% of Smith & Nephew SNATS shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Koninklijke Philips has higher revenue and earnings than Smith & Nephew SNATS.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Smith & Nephew SNATS	$6.16B	2.21	$625M	N/A	N/A
Koninklijke Philips	$20.17B	1.28	$1.01B	$1.36	19.28

Smith & Nephew SNATS presently has a consensus target price of $30.93, indicating a potential downside of 4.05%. Given Smith & Nephew SNATS's stronger consensus rating and higher probable upside, equities analysts plainly believe Smith & Nephew SNATS is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Smith & Nephew SNATS	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17
Koninklijke Philips	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80

In the previous week, Koninklijke Philips had 9 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 14 mentions for Koninklijke Philips and 5 mentions for Smith & Nephew SNATS. Koninklijke Philips' average media sentiment score of 0.56 beat Smith & Nephew SNATS's score of 0.54 indicating that Koninklijke Philips is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Smith & Nephew SNATS	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Koninklijke Philips	6 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive

Summary

Koninklijke Philips beats Smith & Nephew SNATS on 9 of the 16 factors compared between the two stocks.

Get Koninklijke Philips News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PHG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PHG vs. The Competition

Export

Metric	Koninklijke Philips	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$25.85B	$5.67B	$6.86B	$23.73B
Dividend Yield	3.20%	1.78%	2.60%	4.22%
P/E Ratio	19.32	23.62	280.72	31.49
Price / Sales	1.28	58.61	588.49	20.19
Price / Cash	8.51	32.53	28.64	18.72
Price / Book	2.03	6.50	11.02	4.83
Net Income	$1.01B	$151.15M	$3.48B	$1.07B
7 Day Performance	4.63%	3.30%	0.57%	0.84%
1 Month Performance	-5.48%	-1.17%	-4.14%	0.59%
1 Year Performance	-0.93%	5.27%	63.23%	20.55%

Koninklijke Philips Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PHG Koninklijke Philips	2.7445 of 5 stars	$26.22 -0.3%	N/A	-0.9%	$25.85B	$20.17B	19.32	65,340	Analyst Forecast Gap Down
MDLN Medline	4.5889 of 5 stars	$39.70 +2.5%	$50.54 +27.3%	N/A	$50.91B	$28.43B	124.06	45,000
GEHC GE HealthCare Technologies	4.7026 of 5 stars	$61.12 +0.9%	$76.41 +25.0%	-0.2%	$27.56B	$20.63B	14.62	54,000	Earnings Report Analyst Forecast Gap Up
ZBH Zimmer Biomet	2.9939 of 5 stars	$92.15 +0.9%	$100.70 +9.3%	+6.9%	$17.67B	$8.23B	23.93	17,000	Positive News Upcoming Earnings
SOLV Solventum	2.9669 of 5 stars	$80.49 +3.2%	$81.91 +1.8%	+22.6%	$13.51B	$8.26B	9.86	20,000	Positive News Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:PHG) was last updated on 8/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Koninklijke Philips (PHG) Competitors

PHG vs. MDLN, GEHC, ZBH, SOLV, and SNN

How does Koninklijke Philips compare to Medline?

Summary

How does Koninklijke Philips compare to GE HealthCare Technologies?

Summary

How does Koninklijke Philips compare to Zimmer Biomet?

Summary

How does Koninklijke Philips compare to Solventum?

Summary

How does Koninklijke Philips compare to Smith & Nephew SNATS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PHG vs. The Competition

Koninklijke Philips Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Koninklijke Philips (PHG) Competitors

PHG vs. MDLN, GEHC, ZBH, SOLV, and SNN

How does Koninklijke Philips compare to Medline?

Does the media favor PHG or MDLN?

Is PHG or MDLN more profitable?

Do analysts prefer PHG or MDLN?

Which has stronger valuation and earnings, PHG or MDLN?

Do institutionals and insiders have more ownership in PHG or MDLN?

Summary

How does Koninklijke Philips compare to GE HealthCare Technologies?

Does the media favor PHG or GEHC?

Do insiders & institutionals believe in PHG or GEHC?

Is PHG or GEHC more profitable?

Which has more volatility & risk, PHG or GEHC?

Is PHG or GEHC a better dividend stock?

Which has stronger valuation and earnings, PHG or GEHC?

Do analysts recommend PHG or GEHC?

Summary

How does Koninklijke Philips compare to Zimmer Biomet?

Is ZBH or PHG more profitable?

Which has better valuation & earnings, ZBH or PHG?

Do insiders & institutionals believe in ZBH or PHG?

Do analysts recommend ZBH or PHG?

Is ZBH or PHG a better dividend stock?

Which has more risk & volatility, ZBH or PHG?

Does the media refer more to ZBH or PHG?

Summary

How does Koninklijke Philips compare to Solventum?

Does the media favor SOLV or PHG?

Which has more volatility & risk, SOLV or PHG?

Do insiders and institutionals have more ownership in SOLV or PHG?

Do analysts recommend SOLV or PHG?

Which has better valuation and earnings, SOLV or PHG?

Is SOLV or PHG more profitable?

Summary

How does Koninklijke Philips compare to Smith & Nephew SNATS?

Is SNN or PHG more profitable?

Which has more risk and volatility, SNN or PHG?

Is SNN or PHG a better dividend stock?

Do insiders & institutionals have more ownership in SNN or PHG?

Which has better valuation & earnings, SNN or PHG?

Do analysts prefer SNN or PHG?

Does the media refer more to SNN or PHG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PHG vs. The Competition

Koninklijke Philips Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools